Identification and treatment of bisphosphonate-associated actinomycotic osteonecrosis of the jaws

Implant Dentistry

Volumn 20, Issue 5, 2011, Pages 331-336

  Lee, Cameron Y S ^a   Pien, Francis D ^b,c   Suzuki, Jon B ^d  

^a Oral   (United States)

^b Private Practice   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Actinomyces; actinomycotic osteonecrosis; antibiotic therapy; bisphosphonate therapy

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN V;

ACTINOMYCES; ACTINOMYCOSIS; AGED; BIOPSY; CLASSIFICATION; COHORT ANALYSIS; DEBRIDEMENT; FEMALE; HUMAN; HYPERBARIC OXYGEN; JAW DISEASE; JAW OSTEONECROSIS; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; REVIEW; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME;

ACTINOMYCES; ACTINOMYCOSIS; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; CLINDAMYCIN; COHORT STUDIES; DEBRIDEMENT; DOXYCYCLINE; ERYTHROMYCIN; FEMALE; HUMANS; HYPERBARIC OXYGENATION; MALE; MANDIBULAR DISEASES; MAXILLARY DISEASES; MIDDLE AGED; PENICILLIN V; PLATELET-RICH PLASMA; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 80053560476     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/ID.0b013e3182310f03     Document Type: Review

References (48)

1. Rogers MJ, Watts DJ, Russell RG. Overview of bisphosphonates. Cancer. 1997;80:1652-1660. (Pubitemid 27444037)
2. Greenberg MS. Intravenous bisphosphonates and osteonecrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98:259-260. (Pubitemid 39200690)
3. Rausch F, Glorieux FH. Osteogenesis imperfecta. Lancet. 2004;363:1377-1385. (Pubitemid 38529880)
4. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induces avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 2003;61:1115-1117. (Pubitemid 37064711)
5. Ruggiero SL, Mehrotra B, Rosenberg TJ, et al. Osteonecrosis of the jaws associated with the used of bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 2004;62:527-534. (Pubitemid 38542516)
6. Dimitrikopoulos I, Magopoulos C, Karakasis D. Bisphosphonate-induced avascular osteonecrosis of the jaws: A clinical report of 11 cases. Int J Oral Maxillofac Surg. 2006;35:588-593. (Pubitemid 43863136)
7. Melo MD, Obeid G. Osteonecrosis of the jaws in patients with a history of receiving bisphosphonate therapy: Strategies for prevention and early recognition. J Am Dent Assoc. 2005;136:1675-1681. (Pubitemid 41810029)
8. Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. 2005; 63:1567-1575. (Pubitemid 41525412)
9. Lazarovici TS, Yahalom R, Taicher S, et al. Bisphosphonate-related osteonecrosis of the jaws: A single center study of 101 patients. J Oral Maxillofac Surg. 2009; 67:850-855.
10. Nase JB, Suzuki JB. Osteonecrosis of the jaws and oral bisphosphonate treatment. J Am Dent Assoc. 2006;137: 1115-1119. (Pubitemid 44367957)
11. Marx RE, Cillo JE Jr, Ulloa JJ. Oral bisphosphonate-induced osteonecrosis: Risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007;65:2397-2410. (Pubitemid 350100982)
12. Fournier P, Boissier S, Filleur S, et al. Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res. 2002;62:6538-6543.
13. Landesberg R, Cozin M, Cremers S, et al. Inhibition of oral mucosal cell wound healing by bisphosphonates. J Oral Maxillofac Surg. 2008;66:839-847. (Pubitemid 351522817)
14. Otto S, Hafner S, Mast G, et al. Bisposphonate-related osteonecrosis of the jaw: Is the pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg. 2010;68:1158-1161.
15. Silverman SL, Landesberg R. Osteonecrosis of the jaw and the role of bisphosphonates: A critical review. Am J Med. 2009; 122;S33-S45.
16. Bauss F, Pfister T, Papapoulos S. Ibandronate uptake in the jaw is similar to long bones and vertebrae in the rat. J Bone Miner Metab. 2008;26:406-413.
17. Bilezikian JP. Osteonecrosis of the jaw-Do bisphosphonates pose a risk? N Engl J Med. 2006;355:2278-2281. (Pubitemid 44837776)
18. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. 2007;65:369-376.
19. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. Ruggiero SL, Dodson TB, Assael LA, et al; American Association of Oral and Maxillofacial Surgeons. J Oral Maxillofac Surg. 2009;67:2-12.
20. Kaplan I, Anavi K, Anavi Y, et al. The clinical spectrum of Actinomycesassociated lesions of the oral mucosa and jawbones: Correlations with histomorphometric analysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:738-746.
21. Naik NH, Russo TA. Bisphosphonaterelated osteonecrosis of the jaw: The role of Actinomyces. Clin Infect Dis. 2009;49:1729-1732.
22. Biasotto M, Chiandussi S, Dore F, et al. Clinical aspects and management of bisphosphonates-associated osteonecrosis of the jaws. Acta Odontol Scand. 2006; 64:348-354. (Pubitemid 44845517)
23. Lee CYS, David T, Nishime M. Use of platelet-rich plasma in the management of oral bisphosphonate-associated osteonecrosis of the jaw: A report of 2 cases. J Oral Implantol. 2007;33:371-382.
24. Hellstein JW, Marek CL. Bisphosphonate osteochemonecrosis (Bis-Phossy Jaw): Is this phossy jaw of the 21st century? J Oral Maxillofac Surg. 2005;63:682-689. (Pubitemid 40602707)
25. Sedghizadeh PP, Kumar SKS, Gorur A, et al. Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy. J Oral Maxillofac Surg. 2008;66:767-775. (Pubitemid 351381805)
26. Mawardi H, Treister N, Richardson P, et al. Sinus tracts-An early sign of bisphosphonate-associated osteonecrosis of the jaws? J Oral Maxillofac Surg. 2009;67:593-601.
27. Wongchuensoontorn C, Liebehenschel N, Wagner K, et al. Pathological fractures in patientscausedbybisphosponaterelated osteonecrosis of the jaws: Report of 3 cases. J Oral Maxillofac Surg. 2009;67: 1311-1316.
28. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data. J Oral Maxillofac Surg. 2009;67: 61-70.
29. Schuster GS. Bacterial and protozoal infections with oral manifestations. Topazian and Goldberg's Oral and Maxillofacial Infections. 2nd ed. Philadelphia, PA: W.B. Saunders Co; 1987:403-407.
30. Thumbigere-Math V, Sabino MA, Gopalakrishnan R, et al. Bisphosphonaterelated osteonecrosis of the jaw: Clinical features, risk factors, management, and treatment outcomes of 26 patients. J Oral Maxillofac Surg. 2009;67:1904-1913.
31. Brooks GF, Butel JS, Morse SA. Non-spore forming gram positive bacilli: Corynebacterium, propionibacterium, listeria, erysipelothrix, actinomycetes, & related pathogens. In: Foltin J, Ransom J, Lebowitz H, Holton B, eds. Jawetz, Melnick & Adelberg's Medical Microbiology. 22nd ed. New York, NY: McGraw Hill Co.; 2001:194-196.
32. Nagler R, Peled M, Laufer D. Cervicofacial actinomycosis. A diagnostic challenge. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83:652-656.
33. Russo TA. Agents of actinomycosis. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell Douglas Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA: Churchill Livingstone; 2010:3209-3219.
34. Suzuki JB, Delisle AL. Pulmonary actinomycosis of periodontal origin. J Periodontol. 1984;55:581-584. (Pubitemid 15208638)
35. Melo M, Obeid G. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy. J Can Dent Assoc. 2005;71:111-113.
36. Engroff S, Kim D. Treating bisphosphonate osteonecrosis of the jaws: Is there a role for resection and vascularized reconstruction? J Oral Maxillofac Surg. 2007;65:2374-2385. (Pubitemid 47588586)
37. Fleisher KE, Doty S, Kottal S, et al. Tetracycline-guided debridement and cone beam tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: A technical note. J Oral Maxillofac Surg. 2008;66:2646-2653.
38. Lee CYS, Suzuki JB. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonateassociated osteonecrosis of the jaws after surgery? Part I: Biological concepts with a review of the literature. Implant Dent. 2009; 18:492-500.
39. Lee CYS, Suzuki JB. CTX biochemical marker of bone metabolism. Is it a reliable predictor of bisphosphonateassociated osteonecrosis of the jaws after surgery? Part II: A prospective clinical study. Implant Dent. 2010;19:29-38.
40. Curi MM, Dib LL, Kowalski LP, et al. Opportunistic actinomycosis in osteoradionecrosis of the jaws in patients affected by head and neck cancer: Incidence and clinical significance. Oral Oncol. 2000;36: 294-299. (Pubitemid 30227712)
41. Hansen T, Wagner W, Kirkpatrick CJ, et al. Infected osteoradionecrosis of the mandible: Follow-up study suggests deterioration in outcome for patients with Actinomyces-positive bone biopsies. Int J Oral Maxillofac Surg. 2006;35:1001-1004. (Pubitemid 44615444)
42. Gaffney RJ, Walsh MA. Cervicofacial actinomycosis: An unusual case of submandibular swelling. J Laryngol Otol. 1993;107:1169-1170. (Pubitemid 24008452)
43. Stanton DC, Balasanian E. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: Review of 33 surgical cases. J Oral Maxillofac Surg. 2009;67:943-950.
44. Marx RE. A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg. 1983;41:351-357. (Pubitemid 13054600)
45. Marx RE, Johnson RP. Studies on the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol. 1987;64:379-390.
46. Store G, Eribe ERK, Olsen I. DNADNA hybridization demonstrates multiple bacteria in osteoradionecrosis. Int J Oral Maxillofac Surg. 2005;34:193-196. (Pubitemid 40197769)
47. Store G, Olsen I. Scanning and transmission electron microscopy demonstrates bacteria in osteoradionecrosis. Int J Oral Maxillofac Surg. 2005;34:777-781.
48. O'Ryan FS, Khoury S, Liao W, et al. Intravenous bisphosphonate-related osteonecrosis of the jaws: Bone scintigraphy as an early indicator. J Oral Maxillofac Surg. 2009;67:1363-1372.